Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSIP1 | O75475 | 2/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 4/20 | 0.52 |
| ▸ | CA2 | P00918 | 4/20 | 0.52 |
| ▸ | CA12 | O43570 | 3/20 | 0.52 |
| ▸ | CA3 | P07451 | 3/20 | 0.52 |
| ▸ | CA4 | P22748 | 3/20 | 0.52 |
| ▸ | CA6 | P23280 | 3/20 | 0.52 |
| ▸ | CA5A | P35218 | 3/20 | 0.52 |
| ▸ | CA7 | P43166 | 3/20 | 0.52 |
| ▸ | CA9 | Q16790 | 3/20 | 0.52 |
| ▸ | CA13 | Q8N1Q1 | 3/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.52 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5049079 | 0.93 | PSIP1 (0.52) | PSIP1GAAALDH1A1CYP3A4MAPK1 | |
| SCHEMBL5133527 | 0.93 | PSIP1 (0.52) | PSIP1GAAALDH1A1CYP3A4MAPK1 | |
| SCHEMBL10455034 | 0.87 | PSIP1 (0.74) | PSIP1GAAALDH1A1CYP3A4CA2 | |
| SCHEMBL1368829 | 0.84 | KMT2A (0.51) | GAAALDH1A1CYP3A4MAPK1NPC1 | |
| SCHEMBL3254088 | 0.82 | ALDH1A1 (0.59) | ALDH1A1CYP3A4MAPK1NPC1CA1 | |
| SCHEMBL8993420 | 0.82 | PTGS2 (0.71) | — | |
| SCHEMBL23043593 | 0.80 | PSIP1 (0.58) | PSIP1GAAALDH1A1CYP3A4NPC1 | |
| SCHEMBL8789025 | 0.80 | ALDH1A1 (0.56) | ALDH1A1CYP3A4MAPK1NPC1CA1 | |
| SCHEMBL2914219 | 0.80 | ALDH1A1 (0.56) | ALDH1A1CYP3A4MAPK1NPC1CA1 | |
| SCHEMBL29048488 | 0.79 | ALDH1A1 (0.50) | ALDH1A1CYP3A4MAPK1NPC1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105566182-B | A kind of 2 amino 4（Ethylsulfonyl）The synthetic method of phenol | 苏州天马精细化学品股份有限公司 | 2018-02-13 | — | — | CN | claimed |
| CN-105566182-A | Synthetic method of 2-amino-4-(ethylsulfonyl) phenol | SUZHOU TIANMA SPECIALTY CHEMICALS CO LTD | 2016-05-11 | — | — | CN | claimed |
| EP-3632892-B1 | METHOD FOR PRODUCING 3-ARYLPROPIONAMIDE COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2024-07-31 | — | — | EP | disclosed |
| US-20230312455-A1 | PREPARATION OF SUBSTITUTED ACRYLATE COMPOUND | HUA MEDICINE (SHANGHAI) LTD. (CN) | 2023-10-05 | — | — | US | disclosed |
| US-11773228-B2 | Chemically modified anion exchange membrane and method of preparing the same | DANKOOK UNIVERSITY CHEONAN CAMPUS INDUSTRY ACADEMIC COOPERATION FOUNDATION | 2023-10-03 | — | — | US | disclosed |
| US-20230163345-A1 | LITHIUM FLUORIDE-BASED AND RELATED CATHODE COMPOSITIONS AND BATTERIES COMPRISING THE SAME | SILA NANOTECHNOLOGIES, INC. | 2023-05-25 | — | — | US | disclosed |
| CN-110799490-B | 3-arylpropionamide compound and method for producing 3-arylpropionate compound | 住友化学株式会社 | 2023-05-02 | — | — | CN | disclosed |
| US-11552328-B2 | Lithium battery cell including cathode having metal fluoride core-shell particle | SILA NANOTECHNOLOGIES, INC. (US) | 2023-01-10 | — | — | US | disclosed |
| US-11028056-B2 | Method for producing 3-arylpropionamide compound and 3-arylpropionic acid ester compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-06-08 | — | — | US | disclosed |
| US-20200235420-A1 | LITHIUM FLUORIDE-BASED AND RELATED CATHODE COMPOSITIONS AND BATTERIES COMPRISING THE SAME | SILA NANOTECHNOLOGIES, INC. | 2020-07-23 | — | — | US | disclosed |
| US-20200165209-A1 | METHOD FOR PRODUCING 3-ARYLPROPIONAMIDE COMPOUND AND 3-ARYLPROPIONIC ACID ESTER COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-05-28 | — | — | US | disclosed |
| US-20070135477-A1 | Benzimidazole derivatives and their use as protein kinases inhibitors | ASTEX THERAPEUCTICS, LIMITED (US) | 2007-06-14 | — | — | US | disclosed |
| WO-2006048754-A1 | SULFONYL BENZIMIDAZOLE DERIVATIVES | PFIZER JAPAN INC. (JP) | 2006-05-11 | — | — | WO | disclosed |
| US-20060094750-A1 | Sulfonyl benzimidazole derivatives | KON-I KANA | 2006-05-04 | — | — | US | disclosed |
| EP-0258190-B1 | PROCESS FOR PREPARING AROMATIC ETHERS AND THIOETHERS | CIBA-GEIGY AG (CH) | 1991-11-27 | — | — | EP | disclosed |
| US-4912596-A | Dielectric liquids | BAYER AKTIENGESELLSCHAFT (DE) | 1990-03-27 | — | — | US | disclosed |
| US-4825005-A | Process for the preparation of aromatic ether and thioether compounds | CIBA-GEIGY CORPORATION (US) | 1989-04-25 | — | — | US | disclosed |
| EP-0258190-A2 | Process for preparing aromatic ethers and thioethers | CIBA-GEIGY AG (CH) | 1988-03-02 | — | — | EP | disclosed |
| US-4152510-A | AROMATIC DIAMINE CHAIN EXTENDERS | BAYER AKTIENGESELLSCHAFT (DE) | 1979-05-01 | — | — | US | disclosed |
| US-4151210-A | Process for the production of phenylalkyl sulphones | CIBA-GEIGY CORPORATION (US) | 1979-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230312455-A1 | PREPARATION OF SUBSTITUTED ACRYLATE COMPOUND | ACR, ADCYAP1R1, GNPAT | PSIP1 2008/4885GAA 373/4885ALDH1A1 76/4885 |
| US-20200165209-A1 | METHOD FOR PRODUCING 3-ARYLPROPIONAMIDE COMPOUND AND 3-ARYLPROPIONIC ACID ESTER COMPOUND | AADAC, DDT, NAT1 | PSIP1 3276/4885GAA 443/4885ALDH1A1 116/4885 |
| US-20070135477-A1 | Benzimidazole derivatives and their use as protein kinases inhibitors | CDK1, AURKA, CDK2 | PSIP1 2473/4885GAA 1133/4885ALDH1A1 1157/4885 |
| US-11028056-B2 | Method for producing 3-arylpropionamide compound and 3-arylpropionic acid ester compound | AADAC, DDT, NAT1 | PSIP1 3276/4885GAA 443/4885ALDH1A1 116/4885 |
| US-20060094750-A1 | Sulfonyl benzimidazole derivatives | TRPV1, CNR2, CNR1 | PSIP1 2702/4885GAA 2823/4885ALDH1A1 2810/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.